Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma

Neuroendocrine carcinoma of the cervix is a rare subtype of cervical cancer with a poor prognosis. Primary treatment of this disease involves a combination of surgery, chemotherapy, and radiation. The majority of patients will experience disease recurrence, for which there exist no treatment guideli...

Descripción completa

Detalles Bibliográficos
Autores principales: Towner, Mary, Novak, Karen, Chae, Young Kwang, Matei, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284394/
https://www.ncbi.nlm.nih.gov/pubmed/35846558
http://dx.doi.org/10.1016/j.gore.2022.101039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284394/
https://www.ncbi.nlm.nih.gov/pubmed/35846558
http://dx.doi.org/10.1016/j.gore.2022.101039

Ejemplares similares